Works by Prens, Errol

Results: 88

Hurley III Hidradenitis Suppurativa Has an Aggressive Disease Course.

Published in:

2018

By:

Vanlaerhoven, Annika M.J.D.;
Ardon, Christine B.;
van Straalen, Kelsey R.;
Vossen, Allard R.J.V.;
Prens, Errol P.;
van der Zee, Hessel H.;
Vanlaerhoven, Annika M J D;
Ardon, Christine B;
van Straalen, Kelsey R;
Vossen, Allard R J V;
Prens, Errol P;
van der Zee, Hessel H

Publication type:

Letter

Needle‐free electronically‐controlled jet injector treatment with bleomycin and lidocaine is effective and well‐tolerated in patients with recalcitrant keloids.

Published in:

Lasers in Surgery & Medicine, 2024, v. 56, n. 1, p. 45, doi. 10.1002/lsm.23737

By:

Bekkers, Vazula Zulfra;
Khan, Fatima;
Aarts, Pim;
Zdunczyk, Katarzyna;
Prens, Errol Prospero;
Wolkerstorfer, Albert;
Rissmann, Robert;
van Doorn, Martijn Bastiaan Adriaan

Publication type:

Article

Needle‐free jet injection‐induced small‐droplet aerosol formation during intralesional bleomycin therapy.

Published in:

Lasers in Surgery & Medicine, 2022, v. 54, n. 4, p. 572, doi. 10.1002/lsm.23512

By:

Bik, Liora;
Wolkerstorfer, Albert;
Bekkers, Vazula;
Prens, Errol P.;
Haedersdal, Merete;
Bonn, Daniel;
van Doorn, Martijn B. A.

Publication type:

Article

Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial.

Published in:

2017

By:

Greveling, Karin;
Prens, Errol P.;
van Doorn, Martijn B.

Publication type:

journal article

Getting Into the DNA of Hidradenitis Suppurativa.

Published in:

Experimental Dermatology, 2025, v. 34, p. 1, doi. 10.1111/exd.70088

By:

Prens, Errol P.

Publication type:

Article

A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteers.

Published in:

Experimental Dermatology, 2023, v. 32, n. 7, p. 1028, doi. 10.1111/exd.14808

By:

ten Voorde, Wouter;
Saghari, Mahdi;
Boltjes, Jiry;
de Kam, Marieke L.;
Zhuparris, Ahnjili;
Feiss, Gary;
Buters, Thomas P.;
Prens, Errol P.;
Damman, Jeffrey;
Niemeyer‐van der Kolk, Tessa;
Moerland, Matthijs;
Burggraaf, Jacobus;
van Doorn, Martijn B. A.;
Rissmann, Robert

Publication type:

Article

IL‐17A is a pertinent therapeutic target for moderate‐to‐severe hidradenitis suppurativa: Combined results from a pre‐clinical and phase II proof‐of‐concept study.

Published in:

Experimental Dermatology, 2022, v. 31, n. 10, p. 1522, doi. 10.1111/exd.14619

By:

Kimball, Alexa B.;
Loesche, Christian;
Prens, Errol P.;
Bechara, Falk G.;
Weisman, Jamie;
Rozenberg, Izabela;
Jarvis, Philip;
Peters, Thomas;
Roth, Lukas;
Wieczorek, Grazyna;
Kolbinger, Frank;
Jemec, Gregor B. E.

Publication type:

Article

Registries, multicentre and genome‐wide association studies in hidradenitis suppurativa.

Published in:

Experimental Dermatology, 2022, v. 31, p. 22, doi. 10.1111/exd.14610

By:

Jemec, Gregor B. E.;
del Marmol, Véronique;
Bettoli, Vincenzo;
Augustin, Matthias;
Prens, Errol P.;
Zouboulis, Christos C.

Publication type:

Article

Anti‐COVID‐19 measurements for hidradenitis suppurativa patients.

Published in:

Experimental Dermatology, 2021, v. 30, p. 18, doi. 10.1111/exd.14339

By:

Giamarellos‐Bourboulis, Evangelos J.;
Bettoli, Vincenzo;
Jemec, Gregor B. E.;
Marmol, Veronique;
Marzano, Angelo V.;
Prens, Errol P.;
Tzellos, Thrasyvoulos;
Zouboulis, Christos C.

Publication type:

Article

Target molecules for future hidradenitis suppurativa treatment.

Published in:

Experimental Dermatology, 2021, v. 30, p. 8, doi. 10.1111/exd.14338

By:

Zouboulis, Christos C.;
Frew, John W.;
Giamarellos‐Bourboulis, Evangelos J.;
Jemec, Gregor B.E.;
Marmol, Veronique;
Marzano, Angelo V.;
Nikolakis, Georgios;
Sayed, Christopher J.;
Tzellos, Thrasyvoulos;
Wolk, Kerstin;
Prens, Errol P.

Publication type:

Article

Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments.

Published in:

Experimental Dermatology, 2012, v. 21, n. 10, p. 735, doi. 10.1111/j.1600-0625.2012.01552.x

By:

van der Zee, Hessel H.;
Laman, Jon D.;
Boer, Jurr;
Prens, Errol P.

Publication type:

Article

Is mechanical stress an important pathogenic factor in hidradenitis suppurativa?

Published in:

Experimental Dermatology, 2012, v. 21, n. 3, p. 176, doi. 10.1111/j.1600-0625.2012.01443.x

By:

de Winter, Kim;
van der Zee, Hessel H.;
Prens, Errol P.

Publication type:

Article

Complement Activation in inflammatory Skin Diseases.

Published in:

Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00639

By:

Giang, Jenny;
Seelen, Marc A. J.;
van Doorn, Martijn B. A.;
Rissmann, Robert;
Prens, Errol P.;
Damman, Jeffrey

Publication type:

Article

Enhanced production of biologically active interleukin-1α and interleukin-1β by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1β levels and facilitated interleukin-1 release.

Published in:

European Journal of Immunology, 1995, v. 25, n. 6, p. 1624, doi. 10.1002/eji.1830250623

By:

Debets, Reno;
Hegmans, Joost P. J. J.;
Troost, Roger J. J.;
Benner, Robbert;
Prens, Errol P.

Publication type:

Article

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial.

Published in:

Dermatology & Therapy, 2023, v. 13, n. 5, p. 1099, doi. 10.1007/s13555-023-00913-3

By:

Kimball, Alexa B.;
Prens, Errol P.;
Passeron, Thierry;
Maverakis, Emanual;
Turchin, Irina;
Beeck, Stefan;
Drogaris, Leonidas;
Geng, Ziqian;
Zhan, Tianyu;
Messina, Izabella;
Bechara, Falk G.

Publication type:

Article

Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial.

Published in:

Dermatology & Therapy, 2020, v. 10, n. 6, p. 1415, doi. 10.1007/s13555-020-00456-x

By:

Weyne, Jonathan;
Blauvelt, Andrew;
de Bruin-Weller, Marjolein;
Prens, Errol;
Asbell, Penny;
Sierka, Debra;
Chen, Zhen;
Shumel, Brad

Publication type:

Article

Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial.

Published in:

British Journal of Dermatology, 2024, v. 191, n. 4, p. 508, doi. 10.1093/bjd/ljae144

By:

Alavi, Afsaneh;
Prens, Errol P;
Kimball, Alexa B;
Frew, John W;
Krueger, James G;
Mukhopadhyay, Sutirtha;
Gao, Heli;
Ranganathan, Usha;
Ivanoff, Nathalie B;
Hernandez Daly, Ana C;
Zouboulis, Christos C

Publication type:

Article

Global consensus process to establish a core dataset for hidradenitis suppurativa registries.

Published in:

British Journal of Dermatology, 2024, v. 190, n. 4, p. 510, doi. 10.1093/bjd/ljad454

By:

Wainman, Hannah E;
Chandran, Nisha S;
Frew, John W;
Garg, Amit;
Gibbons, Angela;
Gierbolini, Athena;
Horvath, Barbara;
Jemec, Gregor B;
Kirby, Brian;
Kirby, Joselyn;
Lowes, Michelle A;
Martorell, Antonio;
McGrath, Barry M;
Naik, Haley B;
Oon, Hazel H;
Prens, Errol;
Sayed, Christopher J;
Thorlacius, Linnea;
Zee, Hessel H Van der;
Villumsen, Bente

Publication type:

Article

Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape.

Published in:

British Journal of Dermatology, 2024, v. 190, n. 2, p. 149, doi. 10.1093/bjd/ljad345

By:

Krueger, James G;
Frew, John;
Jemec, Gregor B E;
Kimball, Alexa B;
Kirby, Brian;
Bechara, Falk G;
Navrazhina, Kristina;
Prens, Errol;
Reich, Kristian;
Cullen, Eva;
Wolk, Kerstin

Publication type:

Article

Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study.

Published in:

British Journal of Dermatology, 2023, v. 188, n. 5, p. 601, doi. 10.1093/bjd/ljad010

By:

Dudink, Koen;
Bouwman, Klasiena;
Chen, Yanqing;
DePrimo, Samuel E;
Munoz-Elias, Ernesto J;
Aarts, Pim;
Schappin, Renske;
Florencia, Edwin F;
Heeswijk, Bennie van;
Prens, Lisette M;
Zee, Hessel H van der;
Prens, Errol P;
Straalen, Kelsey R van;
Horváth, Barbara

Publication type:

Article

New insights in hidradenitis suppurativa from a population‐based Dutch cohort: prevalence, smoking behaviour, socioeconomic status and comorbidities*.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 5, p. 814, doi. 10.1111/bjd.20954

By:

Prens, Lisette M.;
Bouwman, Klasiena;
Troelstra, Lisa D.;
Prens, Errol P.;
Alizadeh, Behrooz Z.;
Horváth, Barbara

Publication type:

Article

Evidence that the immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis.

Published in:

2005

By:

Knijff, Esther M;
Kupka, Ralph W;
Ruwhof, Cindy;
Breunis, M Nadine;
Prens, Errol P;
Nolen, Willem A;
Drexhage, Hemmo A

Publication type:

Letter

Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).

Published in:

Journal of Pathology, 2003, v. 199, n. 1, p. 107, doi. 10.1002/path.1263

By:

van der Fits, Leslie;
van der Wel, Leontine I;
Laman, Jon D;
Prens, Errol P;
Verschuren, Martie CM

Publication type:

Article

Interferon-γ-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?

Published in:

Journal of Pathology, 1999, v. 187, n. 3, p. 351, doi. 10.1002/(SICI)1096-9896(199902)187:3<351::AID-PATH227>3.0.CO;2-6

By:

Kooy, Angela J. W.;
Prens, Errol P.;
van Heukelum, Alexander;
Vuzevski, Voijslav D.;
van Joost, Theodoor;
Tank, Bhupendra

Publication type:

Article

IL-1β and IFN-γ induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-γ up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.

Published in:

Journal of Pathology, 1999, v. 187, n. 3, p. 358, doi. 10.1002/(SICI)1096-9896(199902)187:3<358::AID-PATH253>3.0.CO;2-8

By:

Wei, Liu;
Debets, Reno;
Hegmans, Joost J;
Benner, Robbert;
Prens, Errol P.

Publication type:

Article

Expression of interferon-gamma receptors and interferon-gamma-induced up-regulation of intercellular adhesion molecule-1 in basal cell carcinoma; decreased expression of IFN-γR and shedding of ICAM-1 as a means to escape immune surveillance.

Published in:

Journal of Pathology, 1998, v. 184, n. 2, p. 169, doi. 10.1002/(SICI)1096-9896(199802)184:2<169::AID-PATH976>3.0.CO;2-G

By:

Kooy, Angela J. W.;
Tank, Bhupendra;
Vuzevski, Vojislav D.;
Van Joost, Theodoor;
Prens, Errol P.

Publication type:

Article

Accelerated wound healing after wide excisions in Hidradenitis Suppurativa using autologous split-thickness skin grafting and platelet-rich plasma.

Published in:

International Wound Journal, 2017, v. 14, n. 3, p. 583, doi. 10.1111/iwj.12673

By:

Vossen, Allard RJV;
van der Zee, Hessel H;
Prens, Errol P

Publication type:

Article

Hidradenitis suppurativa is not associated with the metabolic syndrome based on body type: A cross-sectional study.

Published in:

Journal of Dermatology (John Wiley & Sons, Inc.), 2017, v. 44, n. 2, p. 154, doi. 10.1111/1346-8138.13572

By:

Vossen, Allard R. J. V.;
Zee, Hessel H.;
Onderdijk, Armanda J.;
Boer, Jurr;
Prens, Errol P.

Publication type:

Article

Allergic contact dermatitis caused by topical sirolimus used as an adjuvant for laser treatment of port wine stains.

Published in:

Contact Dermatitis (01051873), 2016, v. 75, n. 3, p. 184, doi. 10.1111/cod.12589

By:

Greveling, Karin;
Kunkeler, Amalia C. M.;
Prens, Errol P.;
van Doorn, Martijn B. A.

Publication type:

Article

Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa.

Published in:

Drugs, 2021, v. 81, n. 12, p. 1397, doi. 10.1007/s40265-021-01566-2

By:

Aarts, Pim;
Dudink, Koen;
Vossen, Allard R. J. V.;
van Straalen, Kelsey R.;
Ardon, Christine B.;
Prens, Errol P.;
van der Zee, Hessel H.

Publication type:

Article

Cellular and molecular effects of pulsed dye laser and local narrow-band UVB therapy in psoriasis.

Published in:

Lasers in Surgery & Medicine, 2010, v. 42, n. 3, p. 201, doi. 10.1002/lsm.20898

By:

Rácz, Emőke;
de Leeuw, Jaap;
Baerveldt, Ewout M.;
Kant, Marius;
Neumann, H.A. Martino;
van der Fits, Leslie;
Prens, Errol P.

Publication type:

Article

Transient hypertrichosis in a patient with Guillain-Barré syndrome.

Published in:

2007

By:

Ruts, Liselotte;
van Doorn, Pieter A.;
Blankevoort, Jeroen P.;
Prens, Errol P.

Publication type:

Letter

Exfoliative Dermatitis Due to Immunologically Confirmed Carbamazepine Hypersensitivity.

Published in:

Pediatric Dermatology, 1996, v. 13, n. 4, p. 316, doi. 10.1111/j.1525-1470.1996.tb01249.x

By:

Troost, Roger J. J.;
Oranje, Arnold P.;
Lijnen, Raf L. P.;
Benner, Robbert;
Prens, Errol P.

Publication type:

Article

Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial.

Published in:

CTS: Clinical & Translational Science, 2020, v. 13, n. 5, p. 994, doi. 10.1111/cts.12792

By:

Niemeyer‐van der Kolk, Tessa;
Wall, Hein;
Hogendoorn, Geretta K.;
Rijneveld, Rianne;
Luijten, Sascha;
Alewijk, Dirk C.J.G.;
Munckhof, Ellen H.A.;
Kam, Marieke L.;
Feiss, Gary L.;
Prens, Errol P.;
Burggraaf, Jacobus;
Rissmann, Robert;
Doorn, Martijn B.A.

Publication type:

Article

Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers.

Published in:

CTS: Clinical & Translational Science, 2020, v. 13, n. 3, p. 573, doi. 10.1111/cts.12741

By:

Niemeyer‐van der Kolk, Tessa;
Assil, Salma;
Buters, Thomas P.;
Rijsbergen, Melanie;
Klaassen, Erica S.;
Feiss, Gary;
Florencia, Edwin;
Prens, Errol P.;
Burggraaf, Jacobus;
Doorn, Martijn B.A.;
Rissmann, Robert;
Moerland, Matthijs

Publication type:

Article

Comprehensive, Multimodal Characterization of an Imiquimod‐Induced Human Skin Inflammation Model for Drug Development.

Published in:

CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 607, doi. 10.1111/cts.12563

By:

der Kolk, Tessa;
Assil, Salma;
Rijneveld, Rianne;
Klaassen, Erica S.;
Feiss, Gary;
Florencia, Edwin;
Prens, Errol P.;
Burggraaf, Jacobus;
Moerland, Matthijs;
Rissmann, Robert;
Doorn, Martijn B.A.

Publication type:

Article

International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 6, p. e496, doi. 10.1111/jdv.19681

By:

Zouboulis, Christos C.;
Prens, Errol P.;
Sayed, Christopher J.;
Molina‐Leyva, Alejandro;
Bettoli, Vincenzo;
Romanelli, Marco;
Szepietowski, Jacek C.;
Martinez, Angela Llobet;
Kasparek, Torben;
Lobach, Iryna;
Wozniak, Magdalena B.;
Ortmann, Christine‐Elke;
Thomas, Nicolas;
Bachhuber, Teresa;
Ravichandran, Shoba;
Tzellos, Thrasyvoulos

Publication type:

Article

Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three‐year follow‐up data of a single‐blind randomized controlled trial.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 9, p. 1815, doi. 10.1111/jdv.19089

By:

van Huizen, Astrid M.;
van der Kraaij, Gayle E.;
Busard, Celine I.;
Ouwerkerk, Wouter;
van den Reek, Juul M. P. A.;
Menting, Stef P.;
Prens, Errol P.;
Rispens, Theo;
de Vries, Annick;
de Jong, Elke M. G. J.;
Lambert, Jo;
van Doorn, Martijn B. A.;
Spuls, Phyllis I.

Publication type:

Article

Development and validation of IHS4‐55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 2, p. 395, doi. 10.1111/jdv.18632

By:

Tzellos, Thrasivoulos;
van Straalen, Kelsey R.;
Kyrgidis, Athanassios;
Alavi, Afsaneh;
Goldfarb, Noah;
Gulliver, Wayne;
Jemec, Gregor B. E.;
Lowes, Michelle A.;
Marzano, Angelo Valerio;
Prens, Errol P.;
Sayed, Christopher J.;
van der Zee, Hessel H.;
Zouboulis, Christos C.

Publication type:

Article

Laser hair removal alters the disease course in mild hidradenitis suppurativa.

Published in:

Journal der Deutschen Dermatologischen Gesellschaft, 2018, v. 16, n. 7, p. 901, doi. 10.1111/ddg.13563

By:

Vossen, Allard R. J. V.;
van der Zee, Hessel H.;
Terian, Marinka;
van Doorn, Martijn B. A.;
Prens, Errol P.

Publication type:

Article

Laser‐Haarentfernung verändert den Krankheitsverlauf bei leichter Hidradenitis suppurativa.

Published in:

Journal der Deutschen Dermatologischen Gesellschaft, 2018, v. 16, n. 7, p. 901, doi. 10.1111/ddg.13563_g

By:

Vossen, Allard R. J. V.;
van der Zee, Hessel H.;
Terian, Marinka;
van Doorn, Martijn B. A.;
Prens, Errol P.

Publication type:

Article

Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa in a Large, Cross-sectional Dutch Twin Cohort.

Published in:

2020

By:

van Straalen, Kelsey R.;
Prens, Errol P.;
Willemsen, Gonneke;
Boomsma, Dorret I.;
van der Zee, H. H.

Publication type:

journal article

Injection site reactions after subcutaneous oligonucleotide therapy.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 2, p. 340, doi. 10.1111/bcp.12961

By:

Meer, Leonie;
Moerland, Matthijs;
Gallagher, Jolie;
Doorn, Martijn B. A.;
Prens, Errol P.;
Cohen, Adam F.;
Rissmann, Robert;
Burggraaf, Jacobus

Publication type:

Article

In Psoriasis Lesional Skin the Type I Interferon Signaling Pathway Is Activated, Whereas Interferon-α Sensitivity Is Unaltered.

Published in:

Journal of Investigative Dermatology, 2004, v. 122, n. 1, p. 51, doi. 10.1046/j.0022-202X.2003.22113.x

By:

van der Fits, Leslie;
van der Wel, Leontine I.;
Laman, Jon D.;
Prens, Errol P.;
Verschuren, Martie C.M.

Publication type:

Article

Expression of IL-18 in Human Keratinocytes.

Published in:

Journal of Investigative Dermatology, 2000, v. 114, n. 3, p. 598, doi. 10.1046/j.1523-1747.2000.02003.x

By:

Companjen, Arjen R.;
Prens, Errol;
Mee, John B.;
Groves, Richard W.

Publication type:

Article

Differential Role of Lymphocyte Function-Associated Antigens in the Activation of Nickel-Specific Peripheral Blood T Lymphocytes.

Published in:

Journal of Investigative Dermatology, 1991, v. 97, n. 5, p. 885, doi. 10.1111/1523-1747.ep12491623

By:

Prens, Errol P.;
Benne, Klazina;
Van Joost, Theodoor;
Benner, Robbert

Publication type:

Article

The Autologous Mixed Epidermal Cell-T Lymphocyte Reaction Is Elevated in Psoriasis: A Crucial Role for Epidermal HLA-DR<sup>+</sup>/CD1a<sub>-</sub> Antigen-Presenting Cells.

Published in:

Journal of Investigative Dermatology, 1991, v. 96, n. 6, p. 880, doi. 10.1111/1523-1747.ep12475275

By:

Prens, Errol P.;
Benne, Klazina;
Van Joost, Theodoor;
Brenner, Robbert

Publication type:

Article

Interleukin-1 and Interleukin-6 in Psoriasis.

Published in:

Journal of Investigative Dermatology, 1990, v. 95, p. 121S, doi. 10.1111/1523-1747.ep12874991

By:

Prens, Errol P.;
Benne, Klazina;
Damme, Jozef Van;
Bakkus, Marleen;
Brakel, Karin;
Benner, Robbert;
Joost, Theodoor Van

Publication type:

Article

CD40 ligation‐induced cytokine production in human skin explants is partly mediated via IL‐1.

Published in:

International Immunology, 2002, v. 14, n. 6, p. 669, doi. 10.1093/intimm/dxf033

By:

Companjen, Arjen R.;
Wel, Leontine I. van der;
Boon, Louis;
Prens, Errol P.;
Laman, Jon D.

Publication type:

Article

Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.

Published in:

2017

By:

Busard, Celine;
Menting, Stef;
van Bezooijen, Sun-Jine;
van den Reek, Juul;
Hutten, Barbara;
Prens, Errol;
de Jong, Elke;
van Doorn, Martijn;
Spuls, Phyllis

Publication type:

journal article